These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15856755)

  • 21. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
    Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
    Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyneuritis cranialis presenting with anti-GQ1b IgG antibody.
    Edvardsson B; Persson S
    J Neurol Sci; 2009 Jun; 281(1-2):125-6. PubMed ID: 19324375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
    Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
    J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autonomic involvement in Guillain-Barré syndrome].
    Kusunoki S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):878-80. PubMed ID: 17432207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of Guillain-Barre syndrome.
    Tsang RS; Valdivieso-Garcia A
    Expert Rev Anti Infect Ther; 2003 Dec; 1(4):597-608. PubMed ID: 15482157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of autoantibodies against gangliosides in Guillain-Barré syndrome.
    Zhang HL; Gao SJ; Yang Y; Wu J
    Iran J Immunol; 2010 Sep; 7(3):198-9. PubMed ID: 20876991
    [No Abstract]   [Full Text] [Related]  

  • 27. Can subdural hematoma be a trigger for Guillain-Barré syndrome?
    Yardimci N; Gulsen S; Avci AY; Altinors N; Zileli T; Can U
    Int J Neurosci; 2009; 119(3):366-72. PubMed ID: 19116843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome.
    Yuki N; Hartung HP
    N Engl J Med; 2012 Jun; 366(24):2294-304. PubMed ID: 22694000
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbohydrate mimicry: a new paradigm of autoimmune diseases.
    Yuki N
    Curr Opin Immunol; 2005 Dec; 17(6):577-82. PubMed ID: 16229995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The co-occurrence of serologically proven myasthenia gravis and Miller Fisher/Guillain Barré overlap syndrome: a case report.
    Lau KK; Goh KJ; Lee HC; Chan YT; Tan CT
    J Neurol Sci; 2009 Jan; 276(1-2):187-8. PubMed ID: 18804791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic neuromuscular transmission block in Guillain-Barré syndrome associated with anti-GQ1b antibodies.
    Wirguin I; Ifergane G; Almog Y; Lieberman D; Bersudsky M; Herishanu YO
    Neuromuscul Disord; 2002 Mar; 12(3):292-3. PubMed ID: 11801402
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome.
    Nachamkin I; Shadomy SV; Moran AP; Cox N; Fitzgerald C; Ung H; Corcoran AT; Iskander JK; Schonberger LB; Chen RT
    J Infect Dis; 2008 Jul; 198(2):226-33. PubMed ID: 18522505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ataxic Guillain-Barré syndrome with anti-GQIb antibody: relation to Miller Fisher syndrome.
    Derakhshan I
    Neurology; 2000 Nov; 55(9):1419-20. PubMed ID: 11087802
    [No Abstract]   [Full Text] [Related]  

  • 36. [Case report; A case of anti-GD1b antibody positive pure motor form Guillain-Barré syndrome with good response to combined IVIg and steroid therapy].
    Fujimoto T; Fukuda Y; Eguchi K; Kusunoki S
    Nihon Naika Gakkai Zasshi; 2011 Jun; 100(6):1651-3. PubMed ID: 21770292
    [No Abstract]   [Full Text] [Related]  

  • 37. Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
    van Sorge NM; Yuki N; Koga M; Susuki K; Jansen MD; van Kooten C; Wokke JH; van de Winkel JG; van der Pol WL; van den Berg LH
    J Neuroimmunol; 2007 Jan; 182(1-2):177-84. PubMed ID: 17156858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
    Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ataxic form of Guillain-Barr syndrome associated with anti-GD1b IgG antibody.
    Yuki N; Susuki K; Hirata K
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):136-7. PubMed ID: 10864627
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiglycolipid antibodies in Guillain-Barré syndrome and autoimmune neuropathies.
    Kusunoki S
    Am J Med Sci; 2000 Apr; 319(4):234-9. PubMed ID: 10768608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.